DMRA · Damora Therapeutics, Inc.
$30.39
-0.23 (-0.75%)
At close · Aug 26
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.89B
Shares
61.74M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | |
| 8-K | 2026-07-20 | 2026-07-16 | |
| 8-K | 2026-06-17 | 2026-04-28 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-04 | 2026-04-28 | |
| DEF 14A | 2026-04-29 | — | |
| 8-K | 2026-04-20 | 2026-04-17 | |
| 8-K | 2026-03-23 | 2026-03-20 | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-10 | 2026-03-06 | |
| 8-K | 2026-02-11 | 2026-02-10 | |
| 8-K | 2026-02-10 | 2026-02-06 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-06 | 2025-12-31 | |
| DEF 14A | 2025-12-31 | 2026-02-09 | |
| 8-K/A | 2025-12-09 | 2025-11-10 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-06-20 | 2025-06-18 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-30 | 2025-06-18 | |
| 10-K | 2025-03-19 | 2024-12-31 | |
| 10-Q | 2024-11-01 | 2024-09-30 | |
| 8-K | 2024-10-15 | — | |
| 8-K | 2024-10-07 | — | |
| 8-K | 2024-09-18 | 2024-09-16 | |
| 8-K | 2024-09-11 | 2024-09-10 | |
| 8-K | 2024-09-05 | 2024-08-29 | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-06-21 | 2024-06-20 | |
| 10-Q | 2024-04-29 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-20 | |
| 8-K | 2024-03-26 | 2024-03-22 | |
| 10-K | 2024-03-08 | 2023-12-31 | |
| 8-K | 2023-12-21 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-10-23 | — | |
| 8-K | 2023-10-02 | 2023-09-27 | |
| 8-K | 2023-09-26 | 2023-09-20 | |
| 8-K | 2023-08-15 | — | |
| 10-Q | 2023-07-31 | 2023-06-30 | |
| 8-K | 2023-06-15 | 2023-06-14 | |
| 10-Q | 2023-04-28 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 2023-06-14 | |
| 8-K | 2023-03-10 | — | |
| 10-K | 2023-03-09 | 2022-12-31 | |
| 8-K | 2023-01-06 | — | |
| 10-Q | 2022-11-08 | 2022-09-30 | |
| 8-K | 2022-10-31 | — |
Showing 1–50 of 72 filings
Key facts
CIK
1800315
CUSIP
G2646Y104
13F (30d)
102 filings
101 filers
Visit website
Investor relations